The G12D, G12R, and G13D KRAS mutations detected in AMCPAC cell lines were reported in various cancers, such as pancreatic carcinoma, non-small cell lung cancer, stomach cancer, colorectal cancer, and leukemia [31–36]. This evidence concerns the gene KRAS and leukemia.